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The human ribosomal protein L7a is a component of
the major ribosomal subunit. We transiently expressed
in HeLa cells L7a-b-galactosidase fusion proteins and
studied their subcellular localization by indirect immu-
nofluorescence staining with anti-b-galactosidase anti-
bodies. We have identified three distinct domains re-
sponsible for the nuclear targeting of the protein:
domain I, amino acids 23–51; domain II, amino acids
52–100; domain III, amino acids 101–220, each of which
contains at least one nuclear localization signal (NLS).
Through subcellular localization analysis of deletion
mutants of L7a-b-galactosidase chimeras, we demon-
strate that domain II plays a special role because it is
necessary, although not sufficient, to target the chi-
meric b-galactosidase to the nucleoli. In fact, we demon-
strate that the nucleolar targeting process requires the
presence of domain II plus an additional basic domain
that can be represented by an NLS or a basic stretch of
amino acids without NLS activity. Thus, when multiple
NLS are present, each NLS exerts distinct functions.
Domain II drives nucleolar accumulation of a reporter
protein with the cooperative action of a short basic
amino acid sequence, suggesting amechanism requiring
protein-protein or protein-nucleic acid interactions.
The biogenesis of eukaryotic ribosomes is a complex process
that takes place in the cell nucleus. Soon after synthesis in the
cytoplasm, ribosomal proteins (r-proteins)1 are transported to
the nucleus and subsequently accumulated in the nucleoli
where they are associated with the precursor-rRNAs (pre-rR-
NAs), which are concomitantly processed into mature rRNA
molecules (1). The assembled ribosomal subunits are eventu-
ally exported to the cytoplasm to function in protein biosynthe-
sis. Thus, the biogenesis of eukaryotic ribosomes entails an
intensive traffic of molecules across the nuclear membrane
and, therefore, r-proteins are a good model with which to study
the mechanism of nuclear transport and nucleolar accumula-
tion of proteins. The nuclear transport of proteins depends
upon the presence of one or more nuclear localization signals
(NLS). These sequences have been found throughout the
polypeptide chain (2) and, in most cases, consist of either short
basic amino acid sequences like the NLS of the SV40 large
T-antigen (126PKKKRKV132) (3, 4) or longer bipartite se-
quences consisting of two stretches of basic amino acids sepa-
rated by about 10 amino acids (5). NLS are both necessary and
sufficient to target a cytoplasmic protein to the nucleus (4).
Much less is known about the mechanism of nucleolar target-
ing of proteins.
Studies on the nucleolar accumulation of viral proteins have
suggested that, like nuclear transport, nucleolar transfer is
mediated by short amino acid sequences, namely nucleolar
localization signals (NOS) (6–9). A NOS motif, however, is not
present in the cellular nucleolar proteins that have been iden-
tified so far, e.g.NO38 (10), nucleolin (11, 12), NSR1 (13), GAR1
(14). Studies on the targeting mechanism of the nucleolar pro-
tein NO38 have revealed that a domain of 24 amino acids at the
carboxyl terminus, with no similarity to the viral nucleolar
targeting signal, is essential for its nucleolar accumulation
(10). However, when this domain is fused to a reporter protein
it is unable to target the hybrid protein to the nucleolus, indi-
cating that the cooperative action of different domains is re-
quired for the nucleolar accumulation of NO38. The nucleolar
targeting of nucleolin, the major nucleolar protein in vertebrate
cells (15, 16), requires both the glycine/arginine-rich (GAR)
domain (11, 12) and the RNA binding domains. Nevertheless,
the fusion of each of these domains to a reporter protein does
not result in directing the chimeric protein to the nucleolus. A
similar analysis of NSR1, a yeast nucleolar protein related to
mammalian nucleolin, has shown that its nucleolar accumula-
tion is mediated either by different combinations of regions in
the NH2 terminus that contain NLS binding motifs or by the
RNA binding domains (13). Because no membrane envelope is
involved in selecting nucleolar molecules (17), these results
have suggested that nucleolar accumulation of proteins is not
due to one or more general nucleolar targeting signals but
rather to functional interactions between one or more domains
of the protein with other macromolecules residing in the nu-
cleolus. A similar mechanism drives the subnuclear localiza-
tion of a variety of nuclear components, e.g. the nuclear lamin
proteins that specifically assemble to the nuclear membrane
(18), and the splicing factors su(wa) and tra (19).
We describe the three domains of the human r-protein L7a
responsible for its nuclear targeting and nucleolar
accumulation.
EXPERIMENTAL PROCEDURES
Plasmids—All constructs were prepared in pSVEX-bgal, a derivative
of pDEX.2 Briefly, an expression cassette including the b-globin pro-
moter followed by the dihydrofolate reductase cDNA was removed from
pDEX. Then, an EcoRI-XbaI DNA fragment containing the coding se-
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quence, starting at the eighth amino acid codon, of Escherichia coli
LacZ was excised from the vector pC4bgal (20) and cloned in the
EcoRI-XbaI sites of the pDEX vector polylinker. The resulting vector is
indicated as pSVEX-bgal. Two complementary oligonucleotides were
synthesized (59-AATTGAAGCTTCTCTCTCCTCCCGCCGCCCAAGAT-
GGCTGCAGG3-9 and 59-AATTCCTGCAGCCATCTTGGGCGGCGGG-
AGGAGAGAGAAGCTTC-39), coding for the 59-untranslated region and
the start codon of L7a (shown underlined), flanked by HindIII and PstI
recognition sites at the 59 and 39 termini to be used, eventually, to
obtain in-frame fusions to the eighth codon of the b-galactosidase. The
linkers terminated with EcoRI site staggered ends and were inserted in
the EcoRI site of pSVEX-bgal to generate the vector indicated as pLacZ
in Fig. 1A. As a result, the pLacZ vector contained a chimeric cDNA
coding for the 59-untranslated region of L7a and followed by a coding
sequence of a b-galactosidase in which the first eight amino acids at the
NH2 terminus were different from the amino acids of the natural
protein (see Fig. 1B). In DNA transfection experiments, pLacZ produced
a protein localized in the cytoplasm. To produce a protein targeted to
the cell nucleus, we constructed the pLacZ-NLS vector by inserting in
theHindIII-PstI sites of pLacZ a synthetic double strand DNA sequence
coding for the NLS, 126PKKKRKVE133, which is responsible for the
nuclear targeting of the SV40 T-antigen.
To create fusion constructs containing the entire L7a cDNA (pL7a) or
cDNA fragments encoding different domains of the L7a protein, we
FIG. 1. Panel A, restriction map of the pLacZ vector. bp, base pairs. Panel B, nucleotide sequence of the HindIII-PstI linker coding for the
59-untranslated region and start codon (in boldface) of L7a, and the spurious eight NH2-terminal amino acids of b-galactosidase; Val is the first
authentic b-galactosidase amino acid. Panel C, amino acid sequence of human r-protein L7a (GenBank accession number X52138), showing the
nuclear localization-competent domains.
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synthesized appropriate primers to use in polymerase chain reaction
amplification of L7a cDNA templates. Primers used for the amplifica-
tion of cDNA coding for domains in the NH2 moiety of L7a (pL7a1–220,
pL7a1–100, pL7a1–51, pL7a1–40, pL7a1–22, pL7a1–17; see Fig. 2)
were designed to carry at the 59 and 39 termini the recognition sites for
HindIII and PstI, respectively, to allow cloning in the HindIII-PstI sites
of the pLacZ vector. Primers for the amplification of cDNA coding for
the domains in the COOH moiety of L7a (pL7a221–266, pL7a139–266,
pL7a101–266, pL7a52–266, see Fig. 2) or the domain II of L7a (pL7a52–
100, see Fig. 5) were designed to allow cloning in the PstI-EcoRI sites of
the pLacZ vector.
The vectors pL7a52–100-NLS and pL7a101–266-NLS were obtained
by cloning complementary synthetic linkers coding for the NLS se-
quence of the SV40 T-antigen in the HindIII-PstI sites of pL7a52–100
and pL7a101–266. The mutated forms of NLS from SV40 T-antigen
(NLS* vectors in Fig. 5) were obtained using the same procedure as for
the vectors containing the wild type NLS sequence (NLS vectors in Fig.
5) and synthetic oligonucleotide linkers carrying the required mutation.
For vector pL7a52–100-b a HindIII-PstI fragment from pLa7a1–17 was
cloned in the HindIII-PstI sites of pL7a52–100. Vector pL7a52–100-h
was constructed by inserting HindIII-PstI linkers encoding amino acids
12–19 of L7a in the HindIII-PstI sites of pL7a52–100.
The accuracy of all fusion constructs was verified by nucleotide
sequencing, using the dideoxy chain termination procedure (21) as
indicated in the Sequenase 2.0 sequencing kit (U. S. Biochemical Corp.).
Cell Culture and DNA Transfection—HeLa cells (ATCC CCL-2.2)
were cultured in Dulbecco’s modified Eagle’s medium (Life Technolo-
gies, Inc.) supplemented with 10% fetal calf serum (Life Technologies,
Inc.), 5 mM L-glutamine, 50 mg/ml streptomycin, and 50 units/ml peni-
cillin. Cells were seeded on coverslips in 60-mm dishes; 18 h after
plating, DNA transfection was carried out using 10 mg of plasmid DNA
and the calcium phosphate precipitation method (22). 48 h after trans-
fection, the subcellular localization of the b-galactosidase was revealed
by indirect immunofluorescence staining.
Immunofluorescence Microscopy—Cells grown on coverslips were
fixed 48 h after DNA transfection with 3.7% formaldehyde in phos-
phate-buffered saline (PBS), kept for 20 min at room temperature and
then permeabilized in 0.1% Triton X-100 in PBS for 5 min. The cover-
slips were incubated for 15 min at room temperature with a mouse
polyclonal antiserum anti-b-galactosidase (Sigma Immunochemicals,
Germany). The antiserum was used at a 1:600 dilution in a PBS, 0.2%
gelatin solution. Coverslips were washed with PBS, 0.2% gelatin solu-
tion and incubated for 15 min at room temperature with fluorochrome-
conjugated secondary antibodies. As secondary antibodies, an anti-
mouse IgG (Fc-specific) fluorescein isothiocyanate conjugate (Sigma
Immunochemicals) was used at a 1:600 dilution in PBS, 0.2% gelatin.
The coverslips were washed several times with PBS, 0.2% gelatin and
then mounted with Mowiol (Hoechst, Germany) on microscope slides.
Cells were analyzed on a Zeiss Axiovert 10 photomicroscope using a
633 Plan-Apochromat lens, or a Zeiss laser scan microscope (LSM 410),
using fluorescein filters (450–490, FT510-LP520).
RESULTS
L7a Protein, as Well as the NLS from SV40 T-antigen, Direct
b-Galactosidase to the Nucleus—Human r-protein L7a (23) con-
tains 266 amino acid residues, for a molecular mass of 30 kDa
(see Fig. 1C). To identify region(s) of the protein responsible for
its nuclear and nucleolar localization we have constructed and
expressed several chimeras by fusing portions of the L7a cDNA
with the 59 terminus of the coding sequence of the E. coli lacZ
gene (20). The lacZ gene product, b-galactosidase, has been
used extensively as a reporter protein to study nuclear trans-
location of a variety of viral (24), yeast (4, 13, 25), Xenopus (10,
12, 26), and human (27–29) proteins, exploiting both the im-
munodetection of the protein (4, 10, 12, 13, 24–26, 28) and the
b-galactosidase activity that is retained in hybrid proteins (27,
29). In our case, when introduced into mammalian cells, each
construct led to a chimeric L7a-b-galactosidase protein. The
subcellular distribution of the L7a-b-galactosidase chimeric
proteins was examined 48 h after transfection by indirect im-
munofluorescence using anti-b-galactosidase antibodies. As a
control, we used the pLacZ construct (Fig. 1A); the b-galacto-
sidase produced by this vector appeared in the cell cytoplasm
together with some nuclear staining (Figs. 2A and 3). This
nuclear staining could be due to an intrinsic ability of b-galac-
tosidase to enter the nucleus or to technical artifact where
strong cytoplasmic fluorescence at the bottom of the cell makes
it appear as a nuclear fluorescence. To address this issue, we
examined at a confocal microscope cells transfected with pLacZ
vector. Fig. 4 shows a confocal multisection analysis of b-ga-
lactosidase-positive cells (pLacZ in Fig. 4). The nucleus appears
to be free of b-galactosidase, thus confirming that b-galactosid-
ase is an appropriate reporter for nuclear transport studies.
FIG. 2. Diagrams of fusion con-
structs containing the L7a domain
(black bar) fused to b-galactosidase
cDNA, and subcellular localization of
the chimeric protein. L and ¶ indicate
constructs for which immunofluorescence
data, obtained with a Zeiss Axiovert 10
(L) or with a Zeiss laser scan (¶) micro-
scope are shown. Similar immunofluores-
cence data were obtained with the other
constructs (data not shown). Panel A, con-
structs containing domains of the NH2
moiety of L7a. Panel B, constructs con-
taining domains of the COOH moiety of
L7a.
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The b-galactosidase was translocated to the nucleus upon the
addition of the T-antigen NLS sequence, as shown by the
pLacZ-NLS construct (Figs. 2A and 3). A L7a-b-galactosidase
fusion protein, carrying the entire L7a coding sequence (pL7a
in Fig. 2), was imported in the nucleus and accumulated in the
nucleoli, as expected (Figs. 3 and 4).
L7a Protein Contains Multiple NLS—We designed a series
of deletion mutants lacking regions at the COOH or NH2
terminus of L7a in an attempt to identify the domain(s)
responsible for the nuclear import of L7a. The mutant cDNAs
were obtained by using the polymerase chain reaction tech-
nique and were inserted into the pLacZ vector in-frame with
b-galactosidase cDNA (Fig. 1). The whole L7a protein and
pL7a1–220, coding for residues 1–220 of L7a, produced a
protein that entered the nucleus and accumulated in the
nucleoli (Fig. 2A). Deletion of 120 amino acids, as in construct
pL7a1–100 (Fig. 2A), led to a protein still targeted to the
nucleus and which accumulated in the nucleoli (Fig. 3). How-
ever, in all experiments we noted a light immunostaining of
the nucleus which was never observed in experiments with
the entire L7a. Consequently we conducted a confocal anal-
ysis, which demonstrated that nucleoli were strongly stained
in both samples, but nuclei retained a diffuse staining in cells
transfected with the pL7a1–100 construct (Fig. 4). A further
deletion of 50 amino acids, as in construct pL7a1–51, pro-
duced a chimeric protein that entered the nucleus (Figs. 2A
and 3) but did not accumulate in the nucleoli. Thus, in the
latter protein, the processes of entry into the nucleus and
nucleolar accumulation were dissociated. The deletion of an-
other 10 amino acids resulted in a protein distributed in the
nucleus and the cytoplasm (pL7a1–40 in Fig. 4). The trans-
fection of construct pL7a1–22, coding for residues 1–22 of
L7a, or construct pL7a1–17, coding for residues 1–17 of L7a,
completely abolished the nuclear and nucleolar staining in
the transfected cells; in fact, the b-galactosidase produced by
these vectors resides exclusively in the cytoplasm (Fig. 2A).
These results demonstrate that a nuclear targeting signal for
the L7a protein is present in the NH2-terminal domain, more
specifically defined by amino acid residues 22–51, whereas
residues 52–100 might play a role in the nucleolar accumu-
lation of a L7a-b-galactosidase fusion protein.
We also dissected the COOH-terminal moiety of the L7a
protein to look for NLS. We constructed vectors expressing
fusion proteins lacking portions of the NH2-terminal region of
L7a (Fig. 2B). Vector pL7a52–266 coding for residues 52–266 of
L7a gave, like the entire L7a, nucleolar staining of transfected
cells (Figs. 2B and 3). pL7a101–266 produced a protein that
entered the nucleus but did not accumulate in the nucleoli
(Figs. 2B and 3). A further deletion of 38 amino acids, as in the
pL7a139–266 construct, led to a b-galactosidase chimera dis-
tributed between the cytoplasm and the nucleus (Figs. 2B and
3). The COOH-terminal region (pL7a221–266) of L7a did not
direct the reporter protein to the nucleus (Fig. 2B). Thus, it
seems reasonable to conclude that at least one other NLS is
present in the region defined by amino acid residues 101–220 of
L7a.
Subnuclear Localization of L7a-b-Galactosidase Chimaeric
Proteins—We concluded from the data reported above that both
the NH2-terminal and the COOH-terminal moieties of the L7a
protein contain at least one NLS. In fact, the 23–51 amino acid
region is able, as well as the 101–220 amino acid region, to
direct a reporter protein to the cell nucleus. However, only
chimeric proteins containing a domain defined by the 52–100
amino acid region of L7a accumulate in the nucleoli. When
amino acids 52–100 are deleted (constructs pL7a1–51 in Fig.
2A and pL7a101–266 in Fig. 2B), the resulting chimeric protein
does not accumulate in the nucleoli, although it is targeted to
the nucleus. This indicates that the failure of the truncated
protein to accumulate in the nucleoli is not simply due to the
inability to enter the nucleus. To investigate the role of the
domain defined by amino acid residues 52–100 in the nucleolar
accumulation of L7a, other fusion proteins were produced, and
their cellular localization was tested by anti-b-galactosidase
antibodies and visualized through immunofluorescence stain-
ing. The cDNA segment coding for the 52–100 amino acid
region of L7a was first fused to the NH2 terminus of b-galac-
tosidase cDNA, and the chimeric DNA construct pL7a52–100
was transfected into HeLa cells (Figs. 5 and 6). The reporter
protein did not accumulate in the nucleolus; however, it en-
tered the nucleus. Therefore, there is another functional NLS
in the L7a region defined by amino acids 52–100. Interestingly,
a protein containing both the NLS from SV40 T-antigen and
the newly defined nuclear localization-competent domain of
L7a entered the nucleus and accumulated in the nucleoli (Figs.
5 and 6).
Cooperation among Protein Domains Is Required to Direct
a Chimeric Protein to the Nucleoli—To understand whether
the nucleolar accumulation of the chimeric b-galactosidase
produced by construct pL7a52–100-NLS was correlated with
a redundancy of NLS, we added the SV40 T-antigen NLS to
the chimeric protein containing the domain defined by amino
acid residues 101–266 of L7a, which enables targeting of a
reporter protein to the nucleus (construct pL7a101–266-NLS
FIG. 3. Immunofluorescence localization of L7a-b-galactosid-
ase fusion proteins. Cells grown on coverslips were transiently trans-
fected with plasmids encoding the constructs shown in Fig. 2. Cells were
fixed with formaldehyde 48 h after transfection and processed for im-
munofluorescence microscopy, using anti-b-galactosidase polyclonal an-
tibodies as primary antibodies, followed by fluorescein isothiocyanate-
antimouse IgG.
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in Figs. 5 and 6). The b-galactosidase produced by this con-
struct was predominantly nuclear. On the other hand, single
point mutations in SV40 T-antigen NLS, which abolished its
nuclear targeting activity (constructs NLS* in Fig. 5), did not
affect its ability to cooperate in the nucleolar accumulation of
the chimeric b-galactosidase (Fig. 6). These results indicate
that the 52–100 region of L7a plays a fundamental role in the
nucleolar accumulation of L7a, but some helper function is
required, which can be surrogated by an NLS domain, al-
though independent from its nuclear targeting activity. A
constant feature of nuclear targeting signals is a cluster of
basic amino acids; amino acids 1–17 at the NH2 terminus of
L7a represent a positively charged stretch of amino acids
which cannot direct a protein to the nucleus (construct
pL7a1–17 in Fig. 2A). A cDNA construct in which the cDNA
coding for amino acids 1–17 of L7a was fused to the cDNA
coding for the 52–100 amino acid region (construct pL7a52–
100-b) was transfected in HeLa cells and produced a b-galac-
tosidase that was targeted to the nucleoli (see Figs. 5 and 6).
On the other hand, we had already demonstrated that a
mutated SV40 T-antigen NLS, which had lost its ability to
target a protein to the nucleus, was able to cooperate with the
52–100 region of L7a to target a protein to the nucleoli
(constructs pL7a52–100-NLS* in Figs. 5 and 6). Thus, taken
together, these results indicate that a basic domain added to
the 52–100 amino acid region restores the latter’s ability to
target a reporter protein to the nucleolus. Support for this
finding came from an experiment in which we fused the
amino acid region 12–19 of L7a to the 52–100 region (con-
struct pL7a52–100-h in Fig. 5). The 12–19 amino acid region
of L7a does not contain any functional NLS or positively
charged amino acid. The b-galactosidase produced by this
construct was found exclusively in the nucleus of the cell
(Fig. 6).
FIG. 5. Diagrams of fusion con-
structs and subcellular localization
of the chimeric protein. In each con-
struct, the black bar represents an L7a
domain fused to the b-galactosidase.
PKKKRKVE represents the NLS of the
SV40 T-antigen; the NLS* constructs con-
tain mutated forms of NLS. represents
the 1–17 amino acid domain of L7a (MP-
KGKKAKGKKVAPAPA), M represents
the 12–19 stretch of hydrophobic amino
acids of L7a protein, VAPAPAVV. L in-
dicates constructs for which immunofluo-
rescence data are shown. Similar immu-
nofluorescence data were obtained with
other constructs (data not shown).
FIG. 4. Confocal analysis of b-galac-
tosidase localization directed by L7a
or by deletion mutants. Cells grown on
coverslips were transiently transfected
with plasmids encoding the indicated con-
structs. For immunofluorescence stain-
ing, cells were processed as described un-
der “Experimental Procedures” and in the
legend to Fig. 3. The serial optical sec-
tions were obtained by scanning from the
adherent base of the cell to the apical
surface in 0.5-mm steps.
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Nuclear Targeting of the L7a Protein—By using a series of
in-frame lacZ-L7a cDNA fusions we have identified within the
human r-protein L7a three distinct nuclear localization-compe-
tent domains defined by: amino acid residues 23–51 (domain I),
amino acid residues 52–100 (domain II), and amino acid resi-
dues 101–220 (domain III). The addition of each of these do-
mains at the NH2 terminus of b-galactosidase resulted in nu-
clear localization of the reporter protein in cells transfected
with a vector carrying the fusion cDNA. Besides having unique
features, these three domains share a high content of basic
amino acids.
Domain I contains peptide 34KRPKNFGIGQDIQPKR49
(boldface in Fig. 1C), which could represent a bipartite NLS
consensus sequence similar to the NLS of nucleoplasmin (30);
however, a chimeric L7a-b-galactosidase protein in which the
putative bipartite NLS has been disrupted (see construct
pL7a1–40 in Fig. 2A), still enters the nucleus albeit less effi-
ciently (pL7a1–40 in Fig. 4). When peptide 34KRPKNF-
GIGQDIQPKR49 is removed from the natural L7a context, as in
the fusion protein where the peptide is located at the NH2
terminus of b-galactosidase (not shown), it is unable to direct
the fusion protein to the nucleus. Thus, even though endowed
with NLS activity, the 34KRPKNFGIGQDIQPKR49 peptide is
not comparable to the SV40 large T-antigen NLS. It is suffi-
cient that the T-antigen NLS prototype be exposed on the
protein surface (2) to interact with the receptor responsible for
triggering the nuclear import (31), whereas, in addition to
correct positioning, a weak NLS seems to require additional
sequences in the natural protein to be fully efficient, as re-
ported for the nsp2 protein (24) and the NLS of polyoma T-
antigen (32). A tetrapeptide consensus (KR/KXR/K) has been
detected in a significant number of nuclear localization signals
(33); the tetrapeptide 34KRPK37 (underlined in Fig. 1C) fitting
the consensus could be involved in the partial nuclear localiza-
tion of the chimeric protein containing a disrupted putative
bipartite NLS (pL7a1–40 in Fig. 4).
Domain II, comprising amino acid residues 52–100, contains
a single cluster of amino acids, 72KRLK75 (boldface and under-
lined in Fig. 1C), which fits the NLS consensus tetrapeptide
proposed by Chelsky et al. (33). The region is positively
charged, containing 11 positively charged residues versus one
aspartate residue. A chimeric b-galactosidase carrying domain
II of L7a at the NH2 terminus translocates to the nucleus.
However, a R73N mutation did not affect the NLS activity of
this region (not shown), indicating that such a strict clustering
of positively charged amino acids is not a prerequisite for
nuclear targeting. Again, the nuclear targeting of a reporter
protein cannot be ascribed simply to the presence of the short
peptide sequence because it occurred only when a contribution
in terms of sequence or folding was supplied by the natural
protein context.
The third nuclear localization-competent domain, domain
III, spans through residues 101–220. In fact, whereas the 101–
266 amino acid region of L7a directed the reporter protein
b-galactosidase to the nucleus (see Fig. 2B), the COOH-termi-
nal region defined by amino acid residues 221–266 did not (see
Fig. 2B). In the 101–220 amino acid region two peptides,
110KKQRLLARAEKK121 and 120KKAAGKGDVPTKR132, could
represent partially overlapping bipartite NLS (boldface in Fig.
1C). Construct pL7a101–266, which includes the putative mul-
tiple NLS region, produced a b-galactosidase targeted to the
nucleus (Figs. 2B and 3); deletion of the region resulted in a
reporter protein that had lost almost completely the ability to
translocate to the nucleus (Figs. 2B and 3). However, fusion of
the peptide 110KKQRLLARAEKK121 to the NH2 terminus of
b-galactosidase did not result in nuclear targeting. It is feasible
that a cumulative effect, which includes a protein context con-
tribution, can overcome the low efficiency of a single NLS.
The efficiency of nuclear translocation promoted by the three
NLS-containing domains is different: domains II and III are
more efficient than domain I (see Figs. 2–6).
Nucleolar Accumulation of the L7a Protein—Domain II, com-
prising amino acid residues 52–100, plays a special role in
nucleolar accumulation of L7a: the chimeric proteins carrying a
deletion of this region (see construct pL7a1–51 in Fig. 2A and
pL7a101–266 in Fig. 2B) did not accumulate in the nucleoli,
although they all translocated to the nucleus with the efficiency
determined by the corresponding NLS. On the other hand, the
presence of domain II alone did not result in the nucleolar
accumulation of the chimeric b-galactosidase (construct
pL7a52–100 in Figs. 5 and 6). A complete process, i.e. nuclear
targeting and nucleolar accumulation of a reporter protein, is
restored when a positively charged region is added to the chi-
meric protein containing domain II. In fact, this cooperative
effect is exerted by: (a) a functional NLS from the SV40 T-
antigen (see construct pL7a52–100-NLS in Figs. 5 and 6); (b) a
mutated, nonfunctional NLS from the SV40 T-antigen (see
constructs pL7a52–100-NLS* in Figs. 5 and 6); (c) the NH2-
terminal stretch of 17 amino acids from L7a which is rich in
positive charges, but unable, alone, to target a reporter protein
to the nucleus (compare construct pL7a1–17 in Fig. 2 and
construct pL7a52–100-b in Figs. 5 and 6). When this positively
charged sequence is replaced by a sequence lacking positively
charged amino acids (i.e. amino acid residues 12–19 from L7a
protein; see construct pL7a52–100-h in Figs. 5 and 6) the
chimeric protein does not accumulate in the nucleoli.
Functional Domains Cooperate in Nucleolar Targeting and
Accumulation—Because no membrane or physical barriers con-
fine nucleoli to the cell nucleus (17), it appears that targeting of
proteins to the nucleoli occurs by means of functional domains
rather than through linear sequences acting as nucleolar local-
ization signals (10, 13, 14, 24, 29). Once in the nucleus, the
FIG. 6. Immunofluorescence localization of L7a-b-galactosid-
ase fusion proteins produced by constructs shown in Fig. 5. For
immunofluorescence staining, cells were processed as described under
“Experimental Procedures” and in the legend to Fig. 3.
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nucleolar protein could accumulate in the nucleolus through
the interaction of functional domains with RNA or proteins
residing in the nucleolus. RNA binding domains are involved in
the nucleolar accumulation of nucleolin, in vertebrates (11),
and of the yeast NSR1 (13). The target sequences of nucleolin
on pre-ribosomal RNA have recently been identified (34). In
both nucleolin and NSR1 the cooperation among RNA binding
domains and other domains facilitates the association of the
protein with the nucleoli. The nucleolar accumulation of r-
proteins could be mediated by RNA-protein interactions, pro-
tein-protein interactions, or even by both kinds of interaction.
A new RNA binding motif has been proposed in L7a based on
the secondary structure rather than on primary sequence ho-
mology with identified RNA binding domain in r-proteins (35).
The putative RNA binding motif includes amino acid residues
130–161, which is a region distinct from the domain involved in
the nucleolar targeting of L7a (amino acid region 52–100).
Acidic nucleolar proteins have been implicated in ribosome
biogenesis (36) because of their structural features and because
they recognize NLS motifs in vitro (37–40). This finding led to
the speculation that the acidic proteins residing in the nucleoli
establish electrostatic interactions with the basic amino acid
residues, including the basic amino acids in the nuclear local-
ization sequence, thus favoring the association of r-proteins
with the ribosomal RNA. Our results are consistent with this
model. In fact, the nucleolar accumulation competence of do-
main II was restored by the addition of a basic domain. We do
not know the mechanism by which this domain can drive the
nucleolar accumulation of a reporter protein; however, our
results are consistent with a model whereby nucleolar target-
ing is not simply mediated by a linear sequence of amino acids,
and more complex interactions involving two or more regions
are needed for a nucleolar protein to accumulate in the nucleoli.
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